Trial Profile

Assessment of Preemptive Analgesic Effect of Caldolor(R) vs. Ofirmev(R) on Third Molar Surgery: A Prospective, Randomized, single-blinded Clinical Trial

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 23 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ibuprofen (Primary) ; Paracetamol
Indications Postoperative pain
Focus Therapeutic Use

Most Recent Events

29 Oct 2018 Results presented in the Cumberland Pharmaceuticals media release.
29 Oct 2018 According to a Cumberland Pharmaceuticals media release, data from this trial was published online in the Journal of Oral and Maxillofacial Surgery, October 15, 2018.
19 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2017.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com